BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 38474214)

  • 1. New Light on Prions: Putative Role of PrP
    Chrobak AA; Pańczyszyn-Trzewik P; Król P; Pawelec-Bąk M; Dudek D; Siwek M
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creutzfeldt-Jakob disease and scrapie prions.
    Prusiner SB
    Alzheimer Dis Assoc Disord; 1989; 3(1-2):52-78. PubMed ID: 2568118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gerstmann-Sträussler-Scheinker disease and "anchorless prion protein" mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Fiorini M; Ferrari S; Meade-White K; Barbieri I; Brocchi E; Ghetti B; Monaco S
    J Biol Chem; 2014 Feb; 289(8):4870-81. PubMed ID: 24398683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
    Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
    Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion infectivity in variant Creutzfeldt-Jakob disease rectum.
    Wadsworth JD; Joiner S; Fox K; Linehan JM; Desbruslais M; Brandner S; Asante EA; Collinge J
    Gut; 2007 Jan; 56(1):90-4. PubMed ID: 16763054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.
    Ferrer I; Puig B; Blanco R; Martí E
    Neuroscience; 2000; 97(4):715-26. PubMed ID: 10842016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.
    Lawson VA; Vella LJ; Stewart JD; Sharples RA; Klemm H; Machalek DM; Masters CL; Cappai R; Collins SJ; Hill AF
    Int J Biochem Cell Biol; 2008; 40(12):2793-801. PubMed ID: 18590830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.
    Giese A; Kretzschmar HA
    Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns.
    Minaki H; Sasaki K; Honda H; Iwaki T
    Neuropathology; 2009 Oct; 29(5):536-42. PubMed ID: 19389076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes.
    Zanusso G; Farinazzo A; Prelli F; Fiorini M; Gelati M; Ferrari S; Righetti PG; Rizzuto N; Frangione B; Monaco S
    J Biol Chem; 2004 Sep; 279(37):38936-42. PubMed ID: 15247220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.
    Choi YP; Head MW; Ironside JW; Priola SA
    Am J Pathol; 2014 Dec; 184(12):3299-307. PubMed ID: 25280631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
    Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
    J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
    Hara H; Sakaguchi S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IL-1β Signaling Normalizes NMDA-Dependent Neurotransmission and Reduces Seizure Susceptibility in a Mouse Model of Creutzfeldt-Jakob Disease.
    Bertani I; Iori V; Trusel M; Maroso M; Foray C; Mantovani S; Tonini R; Vezzani A; Chiesa R
    J Neurosci; 2017 Oct; 37(43):10278-10289. PubMed ID: 28924012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent.
    Nakaoke R; Sakaguchi S; Atarashi R; Nishida N; Arima K; Shigematsu K; Katamine S
    Cell Mol Neurobiol; 2000 Dec; 20(6):717-30. PubMed ID: 11100979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein glycosylation.
    Lawson VA; Collins SJ; Masters CL; Hill AF
    J Neurochem; 2005 May; 93(4):793-801. PubMed ID: 15857383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection.
    Hizume M; Kobayashi A; Teruya K; Ohashi H; Ironside JW; Mohri S; Kitamoto T
    J Biol Chem; 2009 Feb; 284(6):3603-9. PubMed ID: 19074151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.